Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
The FDA is facing criticism for potentially removing key safeguards for high-risk abortion drugs, leading to concerns about endangering women's health. Critics argue that the FDA's policies promote at-home use of abortion drugs despite severe complications. Various voices, including the Supreme Court and politicians like Mike Pence and Rep. Lamborn, are calling for increased oversight and accountability to protect women from the dangers associated with mifepristone.
The FDA abandoned its duty to protect women from the dangers of mifepristone. The last 15 years, abortion pill-related ER visits have risen over 500%. There should always be medical supervision with high-risk medication. The Supreme Court must hold the FDA accountable. https://t.co/FpmbvT5EcW
Supreme Court should overturn FDA approval of dangerous abortion drug mifepristone | @dcexaminer https://t.co/Vb6nFRuiXo https://t.co/PjX5yNI4Rz
The FDA’s own label for chemical abortion drugs says that roughly one in 25 women who take the drugs will end up in the emergency room. They removed reporting requirements for serious complications leaving no credible data tracking. FDA has shown no interest in protecting women…
